Dr. Saad Saad: A successful Life Career

After serving for several decades as a pediatric surgeon in the United States, Dr. Saad Saad one day received a call that would change his life forever. He got a rare opportunity to serve as the personal doctor for the Saudi Royal family. There were two main reasons as to why Dr. Saad Saad was got this great opportunity – He had already stayed in Riyadh, the Saudi City for more than four years. The other reason is that Saad Saad was the single board-certified pediatric surgeon in the United States who spoke both English and Arabic fluently.

 

A new chapter for Dr. Saad Saad

 

Most people would probably wonder why a surgeon from New Jersey could qualify for such a prestigious position. Nonetheless, Dr. Saad Saad success story has a lot to do with his education and upbringing. He was born in Palestine and raised in Kuwait. He came from a family of eight children three of which are surgeons, two Master Degree holders in Engineering, two PhDs and a teacher.

 

When it comes to his educational background, Dr. Saad Saad went to Cairo University in Egypt where he earned his medical degree 47 years ago. He was ranked the second student in his class. After completing his studies in Egypt, Saad Saad proceeded to England where he undertook his internship before moving to the United States 45 year ago. While in the United States, Dr. Saad Saad took did his residency in surgery and pediatric surgery. He also became board-Certified in pediatric surgery, something which is not easy to achieve in the U.S.

 

A renowned and respected pediatric surgeon

 

Dr. Saad Saad has been known for his great and vast experience in pediatric surgery. He has performed thousands of successful pediatric surgeries both in the U.S and abroad. He also has 2 patents under his name and invented numerous pediatric surgical procedures that are currently being used in various hospitals around the world.

 

While in Riyadh, Dr. Saad Saad was posted to work at the King Faisal Specialist Hospital. He was to perform both simple and complex operations as instructed by the Protocol Office and the Chief of the Hospital. He did his first operation on a baby who had been admitted with an aneurysm. It was the first case in the hospital and most people were uncertain if the baby would survive. However, Dr. Saad Saad successfully operated the baby and saved its life.

 

Service both for the rich and the poor

 

Although he worked for a high-end hospital which mainly served the royal family and the rich, Dr. Saad Saad also treated people from the UAE and the Persian Gulf. He admits that he came from a poor family and that he was dedicated to serving everyone regardless of their financial status or religious affiliation. Learn more: https://www.healthgrades.com/physician/dr-saad-saad-ys6d8

 

Dr. Jennifer Walden Is Knowledgeable, Skilled And Down-To-Earth

Dr. Jennifer Walden has been the subject of many articles about beauty and professionalism in the field of cosmetic surgery. Patient testimonials often describe her as someone who takes a genuine interest in the needs of those who seek her help. These testimonials also describe her as having a warm and compassionate personality. As a board certified plastic surgeon, Dr. Walden currently operates a clinic in her home town of Austin, Texas. The philosophy practiced by her and her staff, is one that is dedicated to serving the health and well-being of patients on all levels.

As a woman practicing in the field of cosmetic surgery, she is not reluctant to admit she herself, has used Botox and other dermal fillers as a means to enhance her own appearance. As a mother of twins, she also has an open mind about possibly having repair work done on her abdominal muscles at some point in the future. As a dedicated surgeon, Dr. Jennifer Walden has also been instrumental in developing better tools for breast surgery and has pioneered the use of 3-D imaging for procedures such as vaginal rejuvenation. She currently serves as a consultant with many medical-oriented companies including Ideal Implant and Venus Concept.

Dr. Jennifer Walden’s passion for her chosen field began to shine at an early age. She was Valedictorian of her high school graduating class and Salutatorian of her medical school graduating class. She has co-authored several textbooks related to best plastic surgery and has contributed a significant amount of information to medical journals. While she possesses a great deal of medical knowledge and skill, it is her down-to-earth personality that tends to capture people’s attention. After serving her internship and successively her own practice in New York City, she chose to move back home to Austin so her boys could have a sense of family.

To Learn More Click Here

Eric Lefkofsky- Tempus Unicorn Funding

Tempus Labs is a healthcare technology company founded in the year 2015 by Eric Lefkofsky, the co-founder, and the city’s top entrepreneurs. The Unicorn’s business model is related to the high cancer priorities of the director of the National Cancer Institute that aims at harnessing large Data to impart knowledge, prevent and treat chronic disease cancer. This case mainly is in crucial in determining the kind of therapies that work for particular patients when given the fundamental biology of their tumors.

The company has attained its goals through the financial support from investors. Lefkofsky, the CEO on March 2018 stated through Chicago business insider that its organization received additional funds amounting to $80 million from new and existing investors. Investors initiated fund round to help Tempus lab in reducing the number of cancer patients. These round fund investors include New Enterprise Associates, Revolution Growth, and New Investors Trust Co.

Tempus appeared in the top ten world ranking after voting of top performing healthcare. In about two years since the establishment, it has received approximately $210 million from investors. New Enterprise Associates is the prominent investor of Unicorn Company co-founded by Lefkofsky. During the latest round, Brad Keywell, a business partner and Revolution Ventures founder, Steve Case financed along with the Tempus Chief Executive Officer.

Tempus created an ecosystem of collecting, sorting, analyzing and applying data solutions in treatment procedures on healthcare. This data thus helps in ushering personalized approach to cancer medicine through the collection of patient’s RNA/DNA data combined with any available clinical data. Physicians make more significant decisions concerning therapy when they can access this information. Therefore, therapy outcomes are made more useful to reduce cancer mortality rates.

Lefkofsky initiated a developmental project of building the worlds’ largest molecular and clinical data library that deals in genetics and Precision Medicine. It uses this data to discover the trends in the treatment of cancer and collect molecular information mainly from patients under treatment. Tempus entrepreneurial ventures include Uptake Technologies, the world largest analytics platform, Light Bank, a venture fund focusing on disruptive technologies, Echo Global Logistics, Groupon, a global e-commerce marketplace, Media ocean, a provider of integrated media procurement technologies.

To Read More Click Here

INNOVACARE HEALTH PROVIDING HEALTHCARE SOLUTIONS UNDER THE LEADERSHIP OF RICH SHINTO AND PENELOPE KOKKINIDES

InnovaCare Health is a private company with its headquarters at Fort Lee, N.J, and Puerto Rico. It is a highly integrated payer and provider services organization serving an average of over 400,000 members. InnovaCare’s subsidiary, MMM healthcare has enabled it to provide two health plans: – Medicare y Mucho Mas and PMC Medicare Choice, whose total membership base includes over 200,000 members and a network of over 7,500.

InnovaCare has a provider-centric model, which concentrates on ensuring superior quality and empowered physicians thus optimizing their abilities to deliver innovative, coordinated and quality care at an affordable cost. InnovaCare Health is led by CEO Rick Shinto and COO/CAO Penelope Kokkinides.

 

Rick’s Career

Dr. Rick started as an internist and pulmonologist practicing in Southern California. He served as Chief Operating Officer and Chief Medical Officer for Medical Pathways Management Company then later became Chief Medical Officer at NAMM California. He served as Corporate Vice President of Medical Management for Med Partners between 1996 and 1999 when he left to become Chief Medical Officer at Cal Optima Health Plan in Orange County, California.

 

Rick Shinto’s awards

In 2018, Rick was listed in the Top 25 Minority Executives in Healthcare from Modern Healthcare and received the Access to caring award. In 2012, he received the Ernst and Young Entrepreneur of the Year Award.

 

Penelope’s career

Penelope Kokkinides has served as corporate vice president for Care Management and Disease Management at AmeriChoice, where she was useful in developing and implementing the healthcare model. She also served as COO at Touchstone Health HMO, since 2008.

Penelope has attributed her success as an entrepreneur to teamwork and proper thinking of what needs to be done and how that can improve productivity. Being a traveler, she appreciates the impact of technology on business and communication, especially email.

 

The LAN payment system

InnovaCare Health announced three additions to their leadership team in 2012 where Penelope was listed. Both Rich Shinto and Penelope Kokkinides were instrumental in coming up with Innovative Health Payment System LAN (Learning and Action Network) which is a private-public partnership that helps to move the United States health system toward quality-based payment as opposed to the previous quantity-based systems.

 

Rick Shinto viewed this as a commitment by InnovaCare to ensure progress in the healthcare industry. Penelope also said that the move by these industries would help to improve the quality offered to customers.

 

Sahm Adrangi Believes Fake Traffic is Driving Up QuinStreet’s Stocks

Sahm Adrangi has made a lot of predictions in the past based on the research carried out by his company Kerrisdale Capital Management. These predictions are based on Sahm Adrangi’s suspicions of dishonest business practices that have led investors into putting capital into stocks that are extremely overvalued or essentially worthless. In recent months, Sahm Adrangi has released negative reports on the pharmaceutical company Proteostasis and the Eastman Kodak Company. Proteostasis currently has a medication that is going through its third stage of trials that have used faulty data to make the drug look like it has more effect on the illness it was designed to treat than it actually does. In the case of Kodak Eastman, Sahm Adrangi sees their new KodakCoin and KodakOne as doomed to fail before they even get off of the ground because of legal and technical issues that he thinks they will inevitably be faced.

His newest report is based on the recent rise in stock price of the QuinStreet online marketing business. Despite the excitement of investors, he thinks the reasons they are putting their trust behind QuinStreet are absolutely bogus and were designed to try to bail the company out of inevitable failure. QuinStreet has been struggling financially for years so when they suddenly received an unusual influx of revenue driven by traffic to only one of their clients, it made Sahm Adrangi take notice. Upon further investigation, Kerrisdale Capital Management determined that the increase in traffic that QuinStreet has been experiencing is most likely all computer generated instead of genuine. QuinStreet operates by driving traffic to the sites of their affiliates when their affiliate is given traffic an business through QuinStreet they pay the company for their services. No traffic, no payment. This means that is QuinStreet is indeed generating fake traffic, they are costing their clients money that they should not have to pay.

Kerrisdale Capital Management and Sahm Adrangi have taken a short position on QuinStreet and investors should be very careful if they invest in the future of the online marketing company.

 


 

https://www.bloomberg.com/research/stocks/private/person.asp?personId=252047507&privcapId=109092301&previousCapId=109092301&previousTitle=Kerrisdale%20Capital%20Management%20LLC

Tony Petrello Is Proud Of Multimillion-Dollar Acquisition For Nabors Industries

Nabors Industries has already built its software development and advanced IT department up over the years, but now it will be built on even further thanks to a new acquisition they made with Tesco Corporation. Both Nabors Industries and Tesco Corporation are based in Houston and both have built huge holdings around the Atlantic and gulf area in rigs and modular stations.

Nabors CEO Tony Petrello led negotiations of the acquisition and completed it through a stock transaction, and it gave current Tesco shareholders a 0.68 interest in Nabors Industries common stock. Anthony Petrello believes this deal will bolster current technology resources and will lead to even higher production and returns for investors. The reported revenue for Nabors Industries was up over the course of 2017 according to a company press release.

Tony Petrello has always considered himself to be a good problem solver which led him from a time he solved problems on napkins in middle school to now doing so at one of the world’s largest oil drilling companies. It was Petrello’s former roommate Lloyd Grove, a journalist at the Daily Beast who recounted his ability to work with tough math formulas during his time as a student at Yale. But Petrello suddenly found a new interest in law, and after completing law school he went to a New York law firm in 1979. In 1986, he became a partner at this firm and he helped many of its clients find loopholes in tax reporting, managing mergers and acquisitions, internal audits and securities regulations. In 1991, Petrello left the firm and officially entered the oil industry as chief operating officer of Nabors Industries.

After taking over as CEO in 2011, Tony Petrello started focusing on new automated systems for hybrid rigs and horizontal well technology. He has always brought in large annual compensation, but his largest ever was in 2013 when his base pay plus bonuses, equity, stock options and other assets put him over $68.7 million. Petrello has not equalled that feat since, but he has given away some of that money to non-profit groups around Houston. One of his largest charity recipients has been the Texas Children’s Hospital who he’s supported because of their research institute for neurological studies. Petrello has seen how neurological disorders have affected his daughter Carena, but he believes his gifts to the hospital can shed light on how important the issue is both for the medical community and regular Americans.

For more information about Anthony Petrello, just click here.